MassIVE MSV000094448

Partial Public PXD051135

Mass Spectrometry Imaging of the Extracellular Matrix of the Subchondral Bone in Osteoarthritis Provides Evidence of Tissue Remodeling on the Protein Level that May Precede Cartilage Loss

Description

Osteoarthritis (OA) of the knee is a degenerative condition of the skeletal extracellular matrix (ECM) marked by the loss of articular cartilage and subchondral bone homeostasis that preferentially occurs in the medial side of the joint. Treatments for OA beyond full joint replacement are lacking primarily due to gaps in molecular knowledge of the biological drivers for disease progression. MALDI-Mass Spectrometry Imaging (MSI) allows molecular spatial mapping that is used to investigate the proteomic landscape of OA providing molecular details on the progression of joint degeneration. Entire histologic sections of human tibial plateaus from OA patients and cadaveric controls were treated with collagenase III to target ECM proteins prior to imaging using a timsTOF flex mass spectrometer (Bruker) for the first reported study of MALDI-MSI on bone protein. Data from healthy cadaveric joints and both lateral and medial sides of OA joints were automatically segmented identifying distinct areas of joint damage. Candidate ECM markers comparing either OA to cadaveric tissues or OA medial to OA lateral tissues resulted in 44 candidate peptides that emphasize the significant spatial difference between OA and healthy bone (AUROC >0.85). 31 of 44 peptide markers, resulting from ECM proteins such as COL1A1, COL3A1, and novel detection of COL6A1 and COL6A3 in bone, with significantly elevated abundance in our full OA cohort, indicate disease progression. Spatial maps of these markers revealed distinct tissue damage and disease pathologies in the subchondral bone that are related to protein structural changes in the ECM, changes that may precede overlying cartilage loss in OA. [doi:10.25345/C5HQ3S91K] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Osteoarthritis ; MALDI Imaging ; Extracellular Matrix ; Cartilage ; Subchondral Bone

Contact

Principal Investigators:
(in alphabetical order)
Birgit Schilling, Buck Institute, USA
Submitting User: cschurman
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.